PL1987819T3 - Flupirtyna w postaci do iniekcji - Google Patents

Flupirtyna w postaci do iniekcji

Info

Publication number
PL1987819T3
PL1987819T3 PL08010996T PL08010996T PL1987819T3 PL 1987819 T3 PL1987819 T3 PL 1987819T3 PL 08010996 T PL08010996 T PL 08010996T PL 08010996 T PL08010996 T PL 08010996T PL 1987819 T3 PL1987819 T3 PL 1987819T3
Authority
PL
Poland
Prior art keywords
flupirtin
injectable
presentation type
presentation
type
Prior art date
Application number
PL08010996T
Other languages
English (en)
Inventor
Michael Pieroth
Norbert Stang
Rudy Thoma
Henning Blume
Original Assignee
Teva Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gmbh filed Critical Teva Gmbh
Publication of PL1987819T3 publication Critical patent/PL1987819T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL08010996T 2003-06-20 2004-06-16 Flupirtyna w postaci do iniekcji PL1987819T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10327674A DE10327674A1 (de) 2003-06-20 2003-06-20 Injizierbare Darreichungsform von Flupirtin
EP04739918A EP1638532B1 (de) 2003-06-20 2004-06-16 Injizierbare darreichungsform von flupirtin
EP08010996A EP1987819B1 (de) 2003-06-20 2004-06-16 Injizierbare Darreichungsform von Flupirtin

Publications (1)

Publication Number Publication Date
PL1987819T3 true PL1987819T3 (pl) 2012-09-28

Family

ID=33495162

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08010996T PL1987819T3 (pl) 2003-06-20 2004-06-16 Flupirtyna w postaci do iniekcji
PL04739918T PL1638532T3 (pl) 2003-06-20 2004-06-16 Postacie dawkowane flupirtyny do iniekcji

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL04739918T PL1638532T3 (pl) 2003-06-20 2004-06-16 Postacie dawkowane flupirtyny do iniekcji

Country Status (18)

Country Link
US (1) US20060252804A1 (pl)
EP (2) EP1638532B1 (pl)
JP (1) JP4617303B2 (pl)
KR (1) KR20060025182A (pl)
CN (1) CN1838943A (pl)
AR (1) AR044831A1 (pl)
AT (2) ATE553085T1 (pl)
CA (1) CA2528899A1 (pl)
DE (2) DE10327674A1 (pl)
DK (1) DK1987819T3 (pl)
EA (1) EA008145B1 (pl)
ES (2) ES2322999T3 (pl)
PL (2) PL1987819T3 (pl)
PT (1) PT1987819E (pl)
RS (1) RS20050941A (pl)
TW (1) TWI343261B (pl)
UA (1) UA84155C2 (pl)
WO (1) WO2004112754A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592002B2 (en) * 2005-10-31 2009-09-22 Bioderm Research Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction
JP5283050B2 (ja) * 2005-02-07 2013-09-04 国立大学法人京都大学 繊維強化複合材料
WO2008020584A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8222282B2 (en) * 2008-06-09 2012-07-17 Teva Pharmaceuticals Usa, Inc. Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
US8183267B2 (en) * 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
DE3133519A1 (de) 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
IN172468B (pl) 1990-07-14 1993-08-14 Asta Medica Ag
ATE160696T1 (de) 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
DE19541405A1 (de) 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
JP2781783B2 (ja) * 1996-07-30 1998-07-30 山形日本電気株式会社 半導体装置用パッケージ
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
DE10048969A1 (de) 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
PE20021017A1 (es) * 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible

Also Published As

Publication number Publication date
TW200509984A (en) 2005-03-16
AR044831A1 (es) 2005-10-05
EP1638532A1 (de) 2006-03-29
US20060252804A1 (en) 2006-11-09
UA84155C2 (ru) 2008-09-25
ATE553085T1 (de) 2012-04-15
KR20060025182A (ko) 2006-03-20
PT1987819E (pt) 2012-07-06
EP1987819B1 (de) 2012-04-11
ES2388088T3 (es) 2012-10-08
WO2004112754A1 (de) 2004-12-29
EA200600070A1 (ru) 2006-06-30
CN1838943A (zh) 2006-09-27
DE10327674A1 (de) 2005-01-05
JP4617303B2 (ja) 2011-01-26
PL1638532T3 (pl) 2009-07-31
RS20050941A (sr) 2007-09-21
ES2322999T3 (es) 2009-07-03
EP1638532B1 (de) 2009-02-25
JP2007506660A (ja) 2007-03-22
DK1987819T3 (da) 2012-07-16
EA008145B1 (ru) 2007-04-27
ATE423549T1 (de) 2009-03-15
EP1987819A1 (de) 2008-11-05
CA2528899A1 (en) 2004-12-29
DE502004009045D1 (de) 2009-04-09
TWI343261B (en) 2011-06-11

Similar Documents

Publication Publication Date Title
IL163863A0 (en) Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz
EP1619647A4 (en) DISPLAY DEVICE
GB2403055B (en) Display unit
ZA200406481B (en) Display structure
GB2409323B (en) Display arrangement
PL1987819T3 (pl) Flupirtyna w postaci do iniekcji
TW586639U (en) Expanding structure of display
EP1620834A4 (en) TIME DISPLAY DEVICE
GB0328598D0 (en) Display
GB0320692D0 (en) Ester synthesis
GB0407955D0 (en) Display
IL171945A0 (en) Iodopyrazolyl carboxanilides
GB0315187D0 (en) Application outsourcing
TW585288U (en) Display structure
GB0302120D0 (en) Injectable vial
GB0308210D0 (en) Display
GB0302179D0 (en) Display
GB0315723D0 (en) Display
GB0313354D0 (en) Display
GB0315724D0 (en) Display
GB0329332D0 (en) Display arrangement
GB0305657D0 (en) Display component
GB0413717D0 (en) Improved displays
GB0304521D0 (en) Display library
GB0304657D0 (en) Display library